Company / PP&E per Share
ADMA Biologics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.27
FY2025
5-year range
$0.24 / $0.49
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#72 of 191
Health Care
What the data says
At $0.27, ADMA Biologics, Inc.'s pp&e per share ranks #72 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 4 years of decline, reaching $0.27.
Based on SEC 10-K filings.
0.27 in FY2025 with a 5-year CAGR of -17.1%.
Improved from $0.24 to $0.27 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- -17.1%
- 10-Year CAGR
- -
Sector benchmark
#72 of 191 in Health CareTop 38% of 191This company $0.27 Sector average $18.90
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 13.6% year-over-year.
- Ranks #72 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2017.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | +13.6% |
| FY2024 | $0.24 | -0.3% |
| FY2023 | $0.24 | -18.4% |
| FY2022 | $0.30 | -38.7% |
| FY2021 | $0.49 | -30.8% |
| FY2020 | $0.70 | +2.4% |
| FY2019 | $0.68 | -16.5% |
| FY2018 | $0.82 | -65.3% |
| FY2017 | $2.36 | +1165.9% |
| FY2016 | $0.19 | -27.6% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026